FOCUS4 is a molecularly stratified, multi-site randomised trial programme for patients with colorectal cancer opening in the UK in 2014.
The FOCUS4 programme is designed to identify and register eligible patients, perform a set of molecular tests on a sample of their tumour and then enrol them into a specific randomised trial based on the results of the molecular tests. Each molecularly stratified trial aims to compare a novel intervention to placebo or standard care. Please follow the links on the left for detailed information on the trial.
We happy to announce that we have randomised our first FOCUS4-B patient. This new comparison is testing Aspirin vs Placebo in a blinded randomised comparison.
Be sure to check out our July Newsletter!!
Be sure check out the FOCUS4 DVD here
The FOCUS4 team